The difference in engraftability might be due to relative PAX7 expression, as in vitro expansion over eight passages reduced PAX7 levels in adult satellite cells but not in teratoma-derived skeletal myogenic progenitors (Figures 2A and S2B). Here, PAX7 is linked to teratoma.